AVANIR Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07* |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash | 47.4 | 23.8 | 29.0 | 9.5 | 7.3 |
| Net Receivables | 1.7 | 0.8 | 1.8 | 3.4 | 3.4 |
| Inventories | 0.0 | 0.0 | 0.0 | 2.6 | 3.0 |
| Other Current Assets | 1.4 | 1.2 | 0.8 | 0.7 | 1.3 |
| Total Current Assets | 50.5 | 25.8 | 31.6 | 16.1 | 15.0 |
| Net Fixed Assets | 2.2 | 2.3 | 2.5 | 2.0 | 4.4 |
| Other Noncurrent Assets | 0.8 | 0.9 | 0.9 | 32.7 | 31.2 |
| Total Assets | 53.5 | 29.0 | 34.9 | 50.8 | 50.5 |
| Liabilities and Shareholder's Equity | Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
| Current Liabilities | |||||
| Accounts Payable | 4.0 | 4.0 | 4.4 | 13.9 | 13.9 |
| Short-Term Debt | 0.1 | 0.1 | 0.2 | -- | 0.2 |
| Other Current Liabilities | 3.9 | 3.4 | 3.4 | 5.0 | 5.4 |
| Total Current Liabilities | 7.9 | 7.5 | 8.0 | 18.9 | 19.5 |
| Long-Term Debt | -- | 11.8 | 11.8 | 22.6 | 22.4 |
| Other Noncurrent Liabilities | 11.8 | 12.5 | 13.1 | 15.1 | 14.5 |
| Total Liabilities | 19.7 | 31.8 | 33.0 | 56.5 | 56.4 |
|
Shareholder's Equity | |||||
| Preferred Stock Equity | -- | -- | -- | -- | -- |
| Common Stock Equity | 33.8 | (2.9) | 1.9 | (5.7) | (5.8) |
| Total Equity | 33.8 | (2.9) | 1.9 | (5.7) | (5.8) |
| Shares Outstanding (mil.) | 78.2 | 43.2 | 43.2 | 43.0 | 40.4 |





